SIGASIGA Technologies, Inc.
4.480USD-4.38%Mkt Cap: 318.10M USDP/E: 15.84Last update: 2026-06-01

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox d…

Indicators:|

Key Statistics

Company
Market Cap318.10M USD
Enterprise Value190.71M USD
Revenue (TTM)93.78M USD
Gross Profit64.87M USD
Net Income (TTM)23.28M USD
Revenue/Share1.310 USD
Last Price4.480 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees49
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN
Valuation
P/E (Trailing)15.84
P/E (Forward)4.46
PEG3.37
EV/EBITDA8.99
EV/Revenue2.03
P/S3.58
P/B1.69
EPS (TTM)0.28
EPS (Forward)1.05
52W Range
4.1007% of range9.620
52W High9.620 USD
52W Low4.100 USD
Profitability
Gross Margin68.59%
Oper. Margin-85.24%
EBITDA Margin22.62%
Profit Margin24.61%
ROE11.71%
ROA10.61%
Growth
Revenue Growth-11.30%
Earnings Growth
Cash Flow & Leverage
Operating CF43.47M USD
CapEx (TTM)355.01K USD
FCF Margin63.39%
FCF Yield18.69%
Net Debt-144.96M USD
Net Debt/EBITDA-6.83
Balance Sheet
Debt/Equity0.00
Current Ratio3.25
Quick Ratio2.30
Book Value/Sh2.776 USD
Cash/Share2.029 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div DateApr 7, 2026
Pay DateApr 23, 2026
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.71.72M
Float41.12M
Insiders42.66%
Institutions49.97%
Short Interest
Short Ratio6.9d
Short % Float7.14%
Short % Out.4.62%
Shares Short3.31M
Short (prev mo.)3.24M
Technical
SMA 504.692 (-4.5%)
SMA 2006.613 (-32.3%)
Beta0.85
S&P 52W Chg27.70%
Avg Vol (30d)469.89K
Avg Vol (10d)558.76K
Technical Indicators
RSI (14)52.8
MACD-0.0131
MACD Signal-0.0665
MACD Hist.+0.0534
BB Upper4.941 USD
BB Middle4.560 USD
BB Lower4.179 USD
BB Width16.71%
ATR (14)0.1732 USD
Vol Ratio (20d)0.38x